Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.45 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4771744 | 0.98 | SIGMAR1 (0.47) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL649131 | 0.98 | SIGMAR1 (0.50) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL4134315 | 0.98 | SIGMAR1 (0.50) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL583320 | 0.96 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL1149470 | 0.96 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Hydrochloric Acid SCHEMBL23320287 | 0.96 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Hydrochloric Acid SCHEMBL980555 | 0.96 | SIGMAR1 (0.49) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Hydrochloric Acid SCHEMBL8209880 | 0.95 | SIGMAR1 (0.47) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| Bromide SCHEMBL583318 | 0.95 | SIGMAR1 (0.47) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 | |
| SCHEMBL7044717 | 0.92 | SIGMAR1 (0.43) | SIGMAR1CHRM3CHRM5PLA2G10PLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250073356-A1 | REACTIVE MULTI-ARM POLYMERS HAVING BRANCHED END GROUPS | BOSTON SCIENT SCIMED INC (US) | 2025-03-06 | — | — | US | disclosed |
| US-12178888-B2 | Reactive multi-arm polymers having branched end groups | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| EP-4021960-A1 | REACTIVE MULTI-ARM POLYMERS HAVING BRANCHED END GROUPS | Boston Scientific Scimed Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| CN-114269393-A | Reactive multiarm polymers with branched end groups | 波士顿科学医学有限公司 | 2022-04-01 | — | — | CN | disclosed |
| WO-2021041234-A1 | REACTIVE MULTI-ARM POLYMERS HAVING BRANCHED END GROUPS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2021-03-04 | — | — | WO | disclosed |
| US-20210060183-A1 | REACTIVE MULTI-ARM POLYMERS HAVING BRANCHED END GROUPS | BOSTON SCIENTIFIC SCIMED, INC. | 2021-03-04 | — | — | US | disclosed |
| CN-106890345-B | Contrast agent molecule targeting mitochondria as T2Use of contrast agents | 中国科学院苏州纳米技术与纳米仿生研究所 | 2020-09-01 | — | — | CN | disclosed |
| EP-3177326-A1 | SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS | The Ohio State Innovation Foundation (US) | 2017-06-14 | — | — | EP | disclosed |
| US-20170050988-A1 | DOTAM DERIVATIVES FOR THERAPEUTIC USE | SANOFI (FR) | 2017-02-23 | — | — | US | disclosed |
| US-20170050988-A1 | DOTAM DERIVATIVES FOR THERAPEUTIC USE | SANOFI (FR) | 2017-02-23 | — | — | US | disclosed |
| EP-1641770-A1 | SYNTHESIS OF TRIS N-ALKYLATED 1,4,7,10-TETRAAZACYCLODODECANES | The University of Hong Kong (CN) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005003105-A1 | SYNTHESIS OF TRIS N-ALKYLATED 1,4,7,10-TETRAAZACYCLODODECANES | THE UNIVERSITY OF HONG KONG (CN) | 2005-01-13 | — | — | WO | disclosed |
| US-20040091426-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-05-13 | — | — | US | disclosed |
| EP-1289571-A2 | PROCHELATORS OF RADIOMETAL LABELED MOLECULES | MALLINCKRODT, INC. (US) | 2003-03-12 | — | — | EP | disclosed |
| US-20020187101-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | SCHERING AG (DE) | 2002-12-12 | — | — | US | disclosed |
| US-6426059-B1 | NUCLEAR MAGNETIC RESONANCE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2002-07-30 | — | — | US | disclosed |
| WO-2002024235-A2 | PROCHELATORS OF RADIOMETAL LABELED MOLECULES | UNIVERSITY HOSPITAL (CH) | 2002-03-28 | — | — | WO | disclosed |
| US-6166200-A | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-12-26 | — | — | US | disclosed |
| US-5919433-A | NUCLEAR MAGNETIC RESONANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-07-06 | — | — | US | disclosed |
| EP-0702677-A1 | AROMATIC AMIDE COMPOUNDS AND METAL CHELATES THEREOF | BRACCO International B.V. (NL) | 1996-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040091426-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | ZYX, CCNY, MOK | SIGMAR1 1725/4885CHRM3 1341/4885CHRM5 1682/4885 |
| US-20020187101-A1 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | TFPI, LYN, SYK | SIGMAR1 4236/4885CHRM3 2550/4885CHRM5 3745/4885 |
| US-20170050988-A1 | DOTAM DERIVATIVES FOR THERAPEUTIC USE | SSTR2, SSTR5, SSTR3 | SIGMAR1 710/4885CHRM3 1869/4885CHRM5 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.